Bunil
Bunil Uses, Dosage, Side Effects, Food Interaction and all others data.
Bunil is an atypical antipsychotic of the butyrophenone chemical class, making it structurally related to the typical antipsychotic haloperidol. Bunil has been used for a span of greater than 30 years in the European Union . It has been well established in the treatment of confusion, anxiety, restlessness (particularly in the elderly) and schizophrenia as It is known to be well-tolerated with an excellent safety profile. Recently, it has been studied as a treatment of psychosis related to Parkinson's disease .
Bunil has been demonstrated to produce an antipsychotic effect at doses that cause minimal extrapyramidal symptoms frequently associated with more traditional antipsychotics .
Trade Name | Bunil |
Generic | Melperone |
Melperone Other Names | Melperone |
Type | |
Formula | C16H22FNO |
Weight | Average: 263.356 Monoisotopic: 263.168542495 |
Protein binding | Melperone has a bioavailability of 50-70% [A3145]. |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Bunil is an atypical butyrophenone antipsychotic used to treat sleep disorders, confusion, and psychomotor dysfunction associated with geriatric, psychiatric, and alcohol-dependent patients.
For the treatment of schizophrenia, sleep, disorders, agitation and mentally confused states .
Bunil is also used to associated treatment for these conditions: Confusion, Congenital Dementias, Neurotic Disorders, Psychosis, Sleep Disorder, Psychomotor restlessness
How Bunil works
Bunil demonstrates antagonist activity at D2 dopaminergic and 5HT2A serotonergic receptors . It has a weak affinity to D2 receptors and possesses less risk of inducing dopamine receptor supersensitivity after both acute and chronic administration [L3146]. In addition, the ratio of dopamine D4/D2 occupancy for melperone has been shown to resemble the binding profile of clozapine .
Toxicity
An overdose of Bunil may result in cardiac arrhythmias .
Elimination Route
Oral doses are rapidly absorbed (Tmax 1.5–3.0 hours post oral ingestion)[A3145].
Half Life
Approximately 3-4 hours after oral administration . After intramuscular injection, the half-life has been found to be approximately 6 hours .
Elimination Route
Excreted mainly in the urine, with small amounts of unchanged drug .
Innovators Monograph
You find simplified version here Bunil